Nerai Bio raises €156K Pre-Seed round
11 November 2024· Zurich, Switzerland· health, drug_discovery, ai, robotics, genome_editing, b2b, software_hardware
The funds will be used to ramp up business development, pursue strategic partnerships beyond its core therapeutic focus, and support the progress of its lead drug candidates into key validation studies in preclinical models.
Investors
LeadVenture Kick
Also participating
KickfundVenture (Switzerland)
About Nerai Bio
Stage
Seed
Headquarters
Zurich, Switzerland
Founded
2019
Team Size
6–20
Sectors
healthdrug_discoveryairoboticsgenome_editingb2bsoftware_hardware